The present study showed that the concentration of HE4 in ovarian cancer patients was significantly higher than that in benign ovarian tumor and normal control patients (P<0.01), and no statistically significant differences were observed (P>0.05) between the benign ovarian tumor lesion and normal control groups. This evidence concerns the gene WFDC2 and ovarian benign neoplasm.